ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD16.1

D16.1

Billable

Benign neoplasm of short bones of upper limb

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D16.1 is a billable code used to indicate a diagnosis of benign neoplasm of short bones of upper limb.

Key Diagnostic Point:

D16.1 refers to benign neoplasms located in the short bones of the upper limb, which include the carpal bones and the phalanges. These neoplasms are typically non-cancerous growths that can arise from various tissues, including bone, cartilage, or fibrous tissue. Common types of benign neoplasms in this category include osteochondromas, enchondromas, and fibromas. Clinically, these neoplasms may present with localized pain, swelling, or discomfort, particularly if they impinge on surrounding structures or if they are large enough to cause mechanical issues. Diagnosis is often confirmed through imaging studies such as X-rays, CT scans, or MRIs, which help differentiate benign lesions from malignant tumors. While benign, these neoplasms require monitoring due to the potential for growth or transformation into malignant forms, albeit rare. Regular follow-up and imaging may be necessary to ensure that the neoplasm remains stable and does not exhibit concerning changes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from malignant neoplasms
  • Variability in presentation and symptoms
  • Need for imaging documentation
  • Potential for growth and surveillance requirements

Audit Risk Factors

  • Inadequate documentation of imaging results
  • Failure to note the benign nature of the neoplasm
  • Lack of follow-up notes indicating surveillance
  • Misclassification as malignant neoplasm

Specialty Focus

Medical Specialties

Orthopedic Surgery

Documentation Requirements

Detailed imaging reports, surgical notes if applicable, and follow-up care documentation.

Common Clinical Scenarios

Evaluation of a patient with a painful wrist mass, incidental finding on X-ray, or pre-operative assessment for excision.

Billing Considerations

Ensure clear documentation of the benign nature and any imaging studies performed.

Radiology

Documentation Requirements

Comprehensive imaging reports detailing the characteristics of the neoplasm.

Common Clinical Scenarios

Imaging for a suspected benign bone lesion, follow-up imaging to assess growth.

Billing Considerations

Accurate description of imaging findings is crucial for proper coding.

Coding Guidelines

Inclusion Criteria

Use D16.1 When
  • According to ICD
  • 10 coding guidelines, D16
  • 1 should be used when a benign neoplasm is confirmed through imaging or biopsy
  • It is important to document the specific location and type of neoplasm

Exclusion Criteria

Do NOT use D16.1 When
  • Exclusion criteria include any malignant transformation or misdiagnosis

Related ICD-10 Codes

Related CPT Codes

20680CPT Code

Arthrocentesis, aspiration and/or injection into a major joint or bursa

Clinical Scenario

Used when a patient presents with joint swelling due to a benign neoplasm.

Documentation Requirements

Document the reason for the procedure and findings.

Specialty Considerations

Orthopedic documentation should include details of the neoplasm.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D16.1 provides a clear classification for benign neoplasms of the upper limb, which was less specific in ICD-9.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of data collection and reimbursement processes. D16.1 provides a clear classification for benign neoplasms of the upper limb, which was less specific in ICD-9.

Reimbursement & Billing Impact

reimbursement processes. D16.1 provides a clear classification for benign neoplasms of the upper limb, which was less specific in ICD-9.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What imaging is required to confirm a diagnosis of D16.1?

Imaging studies such as X-rays, CT scans, or MRIs are typically required to confirm the presence and nature of the benign neoplasm.